%0 Journal Article
%T Fruquintinib for refractory colorectal cancer in a pre-treated 82-year-old patient achieved a progression-free survival of 25 months: a case report
%A Wang, Yi
%A Li, Jianjiong
%A Xu, Qiyang
%A Li, Kai
%A Zhang, Chen
%A Chen, Ping
%J Journal of Gastrointestinal Oncology
%D 2022
%B 2022
%9 
%! Fruquintinib for refractory colorectal cancer in a pre-treated 82-year-old patient achieved a progression-free survival of 25 months: a case report
%K 
%X 
%U https://jgo.amegroups.org/article/view/69166
%V 13
%N 5
%P 2667-2671
%@ 2219-679X